| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $17.3M | — | +20.6% |
| SG&A Expense | $6.6M | — | +80.8% |
| Operating Income | -$24.0M | — | -59.4% |
| Income Tax | $0 | — | — |
| Net Income | -$21.7M | — | -48.9% |
| EPS (Basic) | -$0.64 | — | +93.2% |
| EPS (Diluted) | -$0.64 | — | +93.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.3M | +9.7% | +747.1% |
| Short-term Investments | $163.1M | +55.2% | — |
| Current Assets | $215.9M | +40.6% | — |
| Total Assets | $322.5M | +43.3% | — |
| Current Liabilities | $10.6M | -40.8% | — |
| Total Liabilities | $17.9M | -7.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.5M | — | -15.1% |
| Capital Expenditures | $83K | — | — |
| Investing Cash Flow | -$85.4M | — | -732.3% |
| Financing Cash Flow | $117.1M | — | — |
| Free Cash Flow | -$27.6M | — | -15.4% |
| — |
| Stockholders' Equity | $304.6M | +48.2% | +292.5% |